A Roller Coaster from Methamphetamine to Ketamine__臺灣人文及社會科學引文索引資料庫

:::

詳目顯示

第 1 筆 / 總合 1 筆

/1頁

來源文獻資料
摘要
外文摘要
引文資料

題名：	A Roller Coaster from Methamphetamine to Ketamine
書刊名：	Taiwanese Journal of Psychiatry
作者：	黃名琪／林式穀／陳志根
作者(外文)：	Huang, Ming-chyi／Lin, Shih-ku／Chen, Chih-ken
出版日期：	2014
卷期：	28:4
頁次：	頁217-231+a6
主題關鍵詞：	甲基安非他命；安非他命精神病；愷他命精神病；精神分裂症glutamatergic假說；臺灣；Methamphetamine；Amphetamine psychosis；Ketamine psychosis；Glutamatergic hypothesis of schizophrenia；Taiwan
原始連結：	連回原系統網址
相關次數：	被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0) 排除自我引用:1 共同引用:2 點閱:30

臺灣過去十多年來在藥物濫用盛行率方面，似有由甲基安非他命(methamphetamine)轉為愷也命(ketamine)的趨勢。臺灣的學者們有關於甲基安非他命依賴及其引發精神病之研究成果，不論是臨床特徵方面或是誘發基因之相關性調查，在相關研究領域中皆有重要的貢獻與影響。安非他命多巴胺系統的作用以及愷他命對glutamate系統的作用，在過去人體與動物研究中分別模擬了精神分裂症（思覺失調症）在正性與負性症狀的不同面向，讓學者們對精神疾病機轉上有深一的了解，從而也影響了治療。本篇文章的第一部分，我們將針對甲基安非他命濫用與甲基安非他命精神病的進行文獻探討，特別是著重在臺灣進的研究。而在第二部分，我們討論愷他命的生理機多及對人體之作用，特別是長期濫用後之各類副作用，比如膀胱問題、腹部疼痛、神經認知損傷、憂鬱症、精神病、以及成癮問題。由於有關愷他命的神經適應作用以及迴饋機制仍尚未清楚，未來仍需要更多的研究，以精進我們在其臨床使用的益處以及濫用危害的了解。

以文找文

A trend of drug abuse shifting from methamphetamine (METH) to ketamine in Taiwan has been witnessed in Taiwan in the past decade. The research in examining the clinical characteristics and genetic predispositions of METH dependence and psychosis in Taiwan has had a great impact in the pertinent fields. The effects of amphetamine and ketamine have provoked interest in studying the rôle of dopamine theory and glutamatergic hypothesis in schizophrenia, both of which mimic different aspects of the illness. In the first part of this overview paper we review the studies on METH abuse and METH psychosis, particularly those conducted in Taiwan. And in the second part, we address the complex mechanisms of ketamine action and the adverse outcomes associated with chronic ketamine abuse such as cystitis, abdominal pain, neurocognitive impairment, depression, and psychosis. Because the neuroadaptation and reward related to ketamine are not entirely clear, future studies are needed to advance our understanding both its clinical uses and abuse.

以文找文

期刊論文
1.	Chiang, S. C.、Chen, C. Y.、Chang, Y. Y.(2007)。Prevalence of heroin and methamphetamine male users in the northern Taiwan, 1999-2002: capture-recapture estimates。BMC Public Health，7，292。
2.	Li, J. H.、Vicknasingam, B.、Cheung, Y. W.(2001)。To use or not to use: an update on licit and illicit ketamine use。Subst Abuse Rehabil，2，11-20。
3.	Schuckit, M. A.(2006)。Comorbidity between substance use disorders and psychiatric conditions。Addiction，101(Suppl 1)，76-88。
4.	Murray, R. M.、Paparelli, A.、Morrison, P. D.(2013)。What can we learn about schizophrenia from studying the human model, drug-induced psychosis?。Am J Med Genet B Neuropsychiatr Genet，162b，661-670。
5.	Mathias, S.、Lubman, D. I.、Hides, L.(2008)。Substance-induced psychosis: a diagnostic conundrum。J Clin Psychiatry，69，358-367。
6.	Chen, P. H.、Huang, M. C.、Lai, Y. C.(2014)。Serum brainderived neurotrophic factor levels were reduced during methamphetamine early withdrawal。Addict Biol，19，482-485。
7.	Huang, M. C.、Lin, S. K.、Chen, C. H.(2013)。Oxidative stress status in recently abstinent methamphetamine abusers。Psychiatry Clin Neurosci，67，92-100。
8.	Kuo, C. J.、Liao, Y. T.、Chen, W. J.(2011)。Causes of death of patients with methamphetamine dependence: a record-linkage study。Drug Alcohol Rev，30，621-628。
9.	Kuo, C. J.、Tsai, S. Y.、Liao, Y. T.(2012)。Elevated aspartate and alanine aminotransferase levels and natural death among patients with methamphetamine dependence。PLoS One，7，e29325。
10.	Kuo, C. J.、Tsai, S. Y.、Liao, Y. T.(2011)。Risk and protective factors for suicide among patients with methamphetamine dependence: a nested case-control study。J Clin Psychiatry，72，487-493。
11.	Yen, C. F.、Chong, M. Y.(2006)。Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study。Compr Psychiatry，47，215-220。
12.	Lin, S. K.、Ball, D.、Hsiao, C. C.(2004)。Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan。Psychiatry Clin Neurosci，58，206-212。
13.	Wang, L. J.、Chiang, S. C.、Su, L. W.(2012)。Factors associated with drug-related psychiatric disorders and suicide attempts among illicit drug users in Taiwan。Subst Use Misuse，47，1185-1188。
14.	McKetin, R.、McLaren, J.、Lubman, D. I.(2006)。The prevalence of psychotic symptoms among methamphetamine users。Addiction，101，1473-1478。
15.	蔣欣穎、辜彥誠、陳志根(20130600)。Dental Manifestations Leading to Diagnosis of Methamphetamine-induced Psychotic Disorder。臺灣精神醫學，27(2)，161-164+a9。延伸查詢
16.	Chen, C. K.、Chen, S. L.、Mill, J.(2003)。The dopamine transporter gene is associated with attention defi cit hyperactivity disorder in a Taiwanese sample。Mol Psychiatry，8，393-396。
17.	Chen, C. K.、Lin, S. K.(2006)。Reversal of antipsychotic-induced hyperprolactinemia, weight gain and dyslipidemia by aripiprazole: a case report。J Clin Psychiatry，67，1307。
18.	Weber, E.、Blackstone, K.、Iudicello, J. E.(2012)。Neurocognitive defi cits are associated with unemployment in chronic methamphetamine users。Drug Alcohol Depend，125，146-153。
19.	Lin, S. K.、Huang, M. C.、Lin, H. C.(2010)。Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III。Psychiatry Clin Neurosci，64，4-9。
20.	Salo, R.、Ravizza, S.、Fassbender, C.(2011)。Overlapping cognitive patterns in schizophrenia and methamphetamine dependence。Cogn Behav Neurol，24，187-193。
21.	Chen, C. K.、Hu, X.、Lin, S. K.(2004)。Association analysis of dopamine D2-like receptor genes and methamphetamine abuse。Psychiatr Genet，14，223-226。
22.	Li, T.、Chen, C. K.、Hu, X.(2004)。Association analysis of the DRD4 and COMT genes in methamphetamine abuse。AmJ Med Genet B Neuropsychiatr Genet，129，120-124。
23.	Uhl, G. R.、Drgon, T.、Liu, Q. R.(2008)。Genome-wide association for methamphetamine dependence: convergent results from 2 samples。Arch Gen Psychiatry，65，345-355。
24.	Nakamura, K.、Chen, C. K.、Sekine, Y.(2006)。Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations。Hum Genet，120，243-252。
25.	Berman, S.、O'Neill, J.、Fears, S.(2008)。Abuse of amphetamines and structural abnormalities in the brain。Ann N Y Acad Sci，1141，195-220。
26.	Iyo, M.、Sekine, Y.、Mori, N.(2004)。Neuromechanism of developing methamphetamine psychosis: a neuroimaging study。Ann N Y Acad Sci，1025，288-295。
27.	Chou, Y. H.、Huang, W. S.、Su, T. P.、Lu, R. B.、Wan, F. J.、Fu, Y. K.(2007)。Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study。Eur Neuropsychopharmacol，17，46-52。
28.	Brensilver, M.、Heinzerling, K. G.、Swanson, A. N.(2012)。A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation。Drug Alcohol Depend，125，169-172。
29.	Huang, Y. S.、Tang, T. C.、Lin, C. H.(2011)。Effects of motivational enhancement therapy on readiness to change MDMA and methamphetamine use behaviors in Taiwanese adolescents。Subst Use Misuse，46，411-416。
30.	Chiang, S. C.、Chan, H. Y.、Chen, C. H.(2006)。Recidivism among male subjects incarcerated for illicit drug use in Taiwan。Psychiatry Clin Neurosci，60，444-451。
31.	Wang, G. J.、Smith, L.、Volkow, N. D.(2012)。Decreased dopamine activity predicts relapse in methamphetamine abusers。Mol Psychiatry，17，918-925。
32.	Leelahanaj, T.、Kongsakon, R.、Netrakom, P.(2005)。A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis。J Med Assoc Thai，88(Suppl 3)，S43-S52。
33.	Verachai, V.、Rukngan, W.、Chawanakrasaesin, K.(2014)。Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine。Psychopharmacology，231，3099-3108。
34.	Farnia, V.、Shakeri, J.、Tatari, F.(2014)。Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis。Am J Drug Alcohol Abuse，40，10-15。
35.	Raeder, J. C.、Stenseth, L. B.(2000)。Ketamine: a new look at an old drug。Curr Opin Anaesthesiol，13，463-468。
36.	Chen, J. T.、Chen, R. M.(2010)。Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression。Expert Opin Drug Metab Toxicol，6，273-281。
37.	Chen, W. Y.、Huang, M. C.、Lin, S. K.(2014)。Gender differences in subjective discontinuation symptoms associated with ketamine use。Substance abuse treatment, prevention, and policy，9，(39)1-(39)7。
38.	Mion, G.、Villevieille, T.(2013)。Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent fi ndings)。CNS Neurosci Ther，19，370-380。
39.	Miller, K. W.(2002)。The nature of sites of general anaesthetic action。Br J Anaesth，89，17-31。
40.	Hustveit, O.、Maurset, A.、Oye, I.(1995)。Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors。Pharmacol Toxicol，77，355-359。
41.	Levanen, J.、Makela, M. L.、Scheinin, H.(1995)。Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium。Anesthesiology，82，1117-1125。
42.	Tan, S.、Lam, W. P.、Wai, M. S.(2012)。Chronic ketamine administration modulates midbrain dopamine system in mice。PLoS One，7，e43947。
43.	Langston, W. T.、Wathen, J. E.、Roback, M. G.(2008)。Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children: a doubleblind, randomized, placebo-controlled trial。Ann Emerg Med，52，30-34。
44.	Kohrs, R.、Durieux, M. E.(1998)。Ketamine: teaching an old drug new tricks。Anesth Analg，87，1186-1193。
45.	Olney, J. W.、Wozniak, D. F.、Jevtovic-Todorovic, V.(2002)。Drug-induced apoptotic neurodegeneration in the developing brain。Brain Pathol，12，488-498。
46.	Yan, J.、Jiang, H.(2014)。Dual effects of ketamine: neurotoxicity versus neuroprotection in anesthesia for the developing brain。J Neurosurg Anesthesiol，26，155-160。
47.	Liao, Y.、Tang, J.、Corlett, P. R.(2011)。Reduced dorsal prefrontal gray matter after chronic ketamine use。Biol Psychiatry，69，42-48。
48.	Liao, Y.、Tang, J.、Ma, M.(2010)。Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study。Brain，133，2115-2122。
49.	Razoux, F.、Garcia, R.、Lena, I.(2007)。Ketamine, at a dose that disrupts motor behavior and latent inhibition, en hances prefrontal cortex synaptic effi cacy and glutamate release in the nucleus accumbens。Neuropsychopharmacology，32，719-727。
50.	Gable, R. S.(2004)。Acute toxic effects of club drugs。J Psychoact Drugs，36，303-313。
51.	Krystal, J. H.、Karper, L. P.、Seibyl, J. P.(199403)。Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses。Arch Gen Psychiatry，51(3)，199-214。
52.	Green, S. M.、Clark, R.、Hostetler, M. A.(1999)。Inadvertent ketamine overdose in children: clinical manifestations and outcome。Ann Emerg Med，34，492-497。
53.	Schifano, F.、Corkery, J.、Oyefeso, A.(2008)。Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006)。J Clin Psychopharmacol，28，114-116。
54.	Shahani, R.、Streutker, C.、Dickson, B.(2007)。Ketamineassociated ulcerative cystitis: a new clinical entity。Urology，69，810-812。
55.	Chu, P. S.、Ma, W. K.、Wong, S. C.(2008)。The destruction of the lower urinary tract by ketamine abuse: a new syndrome?。BJU Int，102，1616-1622。
56.	Muetzelfeldt, L.、Kamboj, S. K.、Rees, H.(2008)。Journey through the K-hole: phenomenological aspects of ketamine use。Drug Alcohol Depend，95，219-229。
57.	Cottrell, A. M.、Gillatt, D.(2008)。Consider ketamine misuse in patients with urinary symptoms。Practitioner，252，5。
58.	Chen, C. H.、Lee, M. H.、Chen, Y. C.(2011)。Ketaminesnorting associated cystitis。J Formos Med Assoc，110，787-791。
59.	Wong, S. W.、Lee, K. F.、Wong, J.(2009)。Dilated common bile ducts mimicking choledochal cysts in ketamine abusers。Hong Kong Med J，15，53-56。
60.	Poon, T. L.、Wong, K. F.、Chan, M. Y.(2010)。Upper gastrointestinal problems in inhalational ketamine abusers。J Dig Dis，11，106-110。
61.	Yu, W. L.、Cho, C. C.、Lung, P. F.(2014)。Ketamine-related cholangiopathy: a retrospective study on clinical and imaging fi ndings。Abdom Imaging，39，1241-1246。
62.	Morgan, C. J.、Curran, H. V.(2006)。Acute and chronic effects of ketamine upon human memory: a review。Psychopharmacology，188，408-424。
63.	Morgan, C. J.、Muetzelfeldt, L.、Curran, H. V.(2010)。Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study。Addiction，105(1)，121-133。
64.	aan het Rot, M.、Collins, K. A.、Murrough, J. W.(2010)。Safety and effi cacy of repeated-dose intravenous ketamine for treatment-resistant depression。Biol Psychiatry，67，139-145。
65.	Naughton, M.、Clarke, G.、O'Leary, O. F.(2014)。A review of ketamine in affective disorders: current evidence of clinical effi cacy, limitations of use and pre-clinical evidence on proposed mechanisms of action。J Affect Disord，156，24-35。
66.	Malhotra, A. K.、Pinals, D. A.、Adler, C. M.(1997)。Ketamineinduced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics。Neuropsychopharmacology，17，141-150。
67.	Curran, H. V.、Morgan, C.(2000)。Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later。Addiction，95，575-590。
68.	Fine, J.、Finestone, S. C.(1973)。Sensory disturbances following ketamine anesthesia: recurrent hallucinations。Anesth Analg，52，428-430。
69.	Klein, M.、Calderon, S.、Hayes, B.(1999)。Abuse liability assessment of neuroprotectants。Ann N Y Acad Sci，890，515-525。
70.	Duncan, G. E.、Leipzig, J. N.、Mailman, R. B.(1998)。Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation。Brain Res，812，65-75。
71.	Lu, Y.、France, C. P.、Woods, J. H.(1992)。Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists。J Pharmacol Exp Ther，263，499-504。
72.	Morgan, C. J.、Rees, H.、Curran, H. V.(2008)。Attentional bias to incentive stimuli in frequent ketamine users。Psychol Med，38，1331-1340。
73.	Critchlow, D. G.(2006)。A case of ketamine dependence with discontinuation symptoms。Addiction，101，1212-1213。
74.	Morgan, C. J.、Curran, H. V.(2012)。Independent Scientifi c Committee on D: Ketamine use: a review。Addiction，107，27-38。
75.	Lim, D. K.(2003)。Ketamine associated psychedelic effects and dependence。Singapore Med J，44，31-34。
76.	Jansen, K. L.、Darracot-Cankovic, R.(2001)。The nonmedical use of ketamine, part two: A review of problem use and dependence。J Psychoactive Drugs，33，151-158。
77.	Jansen, K. L.(2000)。A review of the nonmedical use of ketamine: use, users and consequences。Journal of Psychoactive Drugs，32(4)，419-433。
78.	Anand, A.、Charney, D. S.、Oren, D. A.(2000)。Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists。Archives of General Psychiatry，57，270-276。
79.	蕭正誠、林式穀、劉興政、呂少鈞、江原麟、陳志根(20030900)。勒戒所與精神專科醫院男性安非他命濫用者之臨床比較。臺灣精神醫學，17(3)，180-188。延伸查詢
80.	周碧瑟、劉美媛、賴明芸、蕭美玲、張鴻仁(19991200)。Time Trend of Substance Use Among Adolescent Students in Taiwan, 1991-1996。臺灣醫學會雜誌，98(12)，827-831。延伸查詢
81.	Chen, W. J.、Fu, T. C.、Ting, T. T.、Huang, W. L.、Tang, G. M.、Hsiao, C. K.、Chen, C. Y.(2009)。Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006。BMC Public Health，9(1)，27-34。

圖書
1.	Crime UNOoDa(2014)。World Drug Report 2014。United Nations。

推文
推薦
引用網址
引用嵌入語法
轉寄

top

:::

相關期刊
相關論文
相關專書
相關著作
熱門點閱

1.	Substance Use Patterns and Cognitive Function in Patients with Methamphetamine Use: A Study of 131 Cases
2.	Dental Manifestations Leading to Diagnosis of Methamphetamine-induced Psychotic Disorder
3.	男海洛因勒戒犯之再犯率的危險因子
4.	勒戒所與精神專科醫院男性安非他命濫用者之臨床比較

無相關博士論文

無相關書籍

無相關著作

1.	臺藝大校園雕塑藝術作品介紹之一：臺灣近代雕塑教育的孕育者--丘雲(1912~2009)
2.	「日本雕刻的近代」系列翻譯(1)--明治的雕刻
3.	邁向近代雕塑的路程--黃土水於日本早期學習歷程與創作發展
4.	心印--1980年代朱銘在美國紐約的奮鬥歷程
5.	陳澄波藝術中的摩登迷戀
6.	試析後90年代透過戲劇展演臺灣歷史的一種美學趨勢轉向--以三位女性劇場創作者的劇作及演出為例
7.	以A/r/tography藝術方法學省思劇場活動在社區文化發展的作用
8.	運用教育戲劇策略在原住民族孩童的傳統婚禮文化學習之探究
9.	社會戲劇遊戲之後設溝通研究
10.	國中表演藝術專家教師班級經營之研究
11.	戲劇教育促進親子溝通之多個案研究
12.	實驗室劇場的《衛城》和生活劇場的《天堂此時》中的亞陶概念和觀眾/演員關係
13.	波瓦的戲劇政治化--從「被壓迫者劇場」到「立法劇場」
14.	批判性展演式教育學：從身體出發，剖析解放教育中的政治
15.	臺灣東北角水湳洞邊陲礦業漁港地景之歷史地理初探

QR Code

臺灣人文及社會科學引文索引資料庫系統

詳目顯示

臺灣人文及社會科學引文索引資料庫